Innovative Product Launches Reflow Medical has recently launched next-generation microcatheters, Cora Flex and Cora Force, indicating ongoing product innovation and a focus on complex cardiovascular treatments, creating opportunities to target healthcare providers adopting cutting-edge technology.

Regulatory Milestones The company has achieved CE Mark certification for its Bare Temporary Spur Stent System, demonstrating its capability to comply with international standards and expanding market access in Europe for sales growth.

Strategic Market Presence Participation in notable industry events like the Society of Interventional Radiology Annual Meeting signals active engagement with key clinical practitioners, opening avenues to establish partnerships and deepen market penetration.

Clinical Evidence Support Reflow Medical has presented clinical trial results for its devices, supporting the efficacy and safety of its solutions, which can be leveraged in sales efforts to build confidence among physicians and hospital procurement teams.

Growth and Funding With revenues estimated between 10 to 25 million dollars and recent funding of 500K, the company appears positioned for growth, offering opportunities to negotiate larger contracts and expand into new territories with targeted outreach.